
Join us on "The Oprah Ozempic Odyssey," where we explore the intriguing world of weight loss through the lens of Oprah Winfrey's recent remarks about the weight loss drug, Ozempic. Dive into the heated debate surrounding the use of weight loss drugs, and discover the pros and cons of Ozempic as we break down its potential benefits and side effects. Through thoughtful discussions and a touch of hum... more
| Publishes | Twice weekly | Episodes | 56 | Founded | 2 years ago |
|---|---|---|---|---|---|
| Number of Listeners | Categories | MedicineHealth & FitnessNutrition | |||

Recent research from the University of Cambridge highlights a key concern with popular weight-loss drugs like Ozempic and Wegovy. These medications sharply reduce appetite, leading to calorie intake dropping by sixteen to thirty-nine percent, which d... more
In the past week, weight loss drugs like Ozempic, Wegovy, and Mounjaro have reshaped global conversations on obesity, marking 2026 as a potential turning point. Firstpost reports that these GLP-1 drugs, originally developed for type two diabetes, tri... more
Novo Nordisk's new drug CagriSema has outperformed Ozempic in a recent Phase III trial for type 2 diabetes patients, according to Clinical Trials Arena. In the REIMAGINE 2 study, CagriSema reduced HbA1c levels by 1.91 percentage points and achieved 1... more
Oprah Winfrey has been candid this week about her ongoing use of GLP-1 medications like those containing semaglutide, the active ingredient in Ozempic, for weight management. In recent interviews promoting her new book Enough: Your Health, Your Weigh... more
People also subscribe to these shows.




4 minute episodes with 2 minutes of ads. What’s the point of this?
Key themes from listener reviews, highlighting what works and what could be improved about the show.
How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.
Apple Podcasts | #68 | |
Apple Podcasts | #52 | |
Apple Podcasts | #138 | |
Apple Podcasts | #164 | |
Apple Podcasts | #188 | |
Apple Podcasts | #237 |
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | Gender Skew | Location | |||
|---|---|---|---|---|---|
| Interests | Professions | Age Range | |||
| Household Income | Social Media Reach | ||||
Exploring the multifaceted topic of weight loss, this series focuses on the implications of using medications like Ozempic as an aid. By framing discussions around Oprah Winfrey's experiences and insights, it also delves into the broader societal impacts and cultural debates related to obesity, personal health, and the stigma surrounding pharmaceutical weight loss options. Emphasizing the importance of informed decision-making, episodes offer expert commentary and personal anecdotes that aim to empower listeners on their journeys toward better health and wellness. Insightful and engaging, the content not only discusses the pros and cons of weight management drugs but also encourages a nuanced view of obesity as a complex health issue rather... more
Rephonic provides a wide range of podcast stats for Oprah's Weight Loss Dilemma: The Ozempic. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oprah's Weight Loss Dilemma: The Ozempic and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oprah's Weight Loss Dilemma: The Ozempic, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Oprah's Weight Loss Dilemma: The Ozempic, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Oprah's Weight Loss Dilemma: The Ozempic has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Oprah's Weight Loss Dilemma: The Ozempic:
1. The Oprah Podcast
2. The Oprah Winfrey Show: The Podcast
3. Oprah's Super Soul
4. The Mel Robbins Podcast
5. GLP-1 Hub: Support, Community, and Weight Loss
Oprah's Weight Loss Dilemma: The Ozempic launched 2 years ago and published 56 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Oprah's Weight Loss Dilemma: The Ozempic from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Oprah's Weight Loss Dilemma: The Ozempic. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Oprah's Weight Loss Dilemma: The Ozempic include:
1. Dr. Ania Jastreboff
2. Oprah Winfrey
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.